Literature DB >> 36014978

HPV-Related Skin Phenotypes in Patients with Inborn Errors of Immunity.

Assiya El Kettani1,2,3, Fatima Ailal1,4, Jalila El Bakkouri1,5, Khalid Zerouali1,2,3, Vivien Béziat6,7, Emmanuelle Jouanguy6,7, Jean-Laurent Casanova6,7,8, Ahmed Aziz Bousfiha1,4.   

Abstract

Patients with inborn errors of immunity (IEI) are prone to develop infections, either due to a broad spectrum of pathogens or to only one microbe. Since skin is a major barrier tissue, cutaneous infections are among the most prevalent in patients with IEI due to high exposures to many microbes. In the general population, human papillomaviruses (HPVs) cause asymptomatic or self-healing infections, but, in patients with IEI, unusual clinical expression of HPV infection is observed ranging from epidermodysplasia verruciformis (EV) (a rare disease due to β-HPVs) to profuse, persistent, and recalcitrant warts (due to α-, γ-, and μ-HPVs) or even tree man syndrome (due to HPV2). Mutations in EVER1, EVER2, and CIB1 are associated with EV phenotype; GATA2, CXCR4, and DOCK8 mutations are typically associated with extensive HPV infections, but there are several other IEI that are less frequently associated with severe HPV lesions. In this review, we describe clinical, immunological, and genetic patterns of IEI related to severe HPV cutaneous infections and propose an algorithm for diagnosis of IEI with severe warts associated, or not, with lymphopenia.

Entities:  

Keywords:  HPV; inborn errors of immunity; skin

Year:  2022        PMID: 36014978      PMCID: PMC9414374          DOI: 10.3390/pathogens11080857

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


1. Introduction

Human papillomaviruses (HPVs) are DNA viruses with a specific tropism to keratinocytes, which are the main component of stratified epithelia, including skin, genital, and laryngeal mucosa. There are more than 200 different genotypes of HPVs classified in five (α-, β-, γ-, μ-, and ν-) genera. HPV subtypes of all genera infect the skin, and only some HPVs of α-genus infect the mucosal epithelia. Some α- and β-HPV types are oncogenic and are associated with benign genital condyloma, cervical and anogenital cancers, and non-melanoma skin cancers, respectively [1,2]. In the general population, HPVs cause asymptomatic or self-healing infections, with spontaneous clearances reported: 23% at 2 months and 66% by 2 years [3,4]. The transmission is from skin-to-skin or mucous-to-mucous contact. Seroprevalence is variable, depending on the HPV genus, age, and screening policy of each country. However, it is estimated to be <40% and 20–65% for oncogenic α-HPV and β-HPVs, respectively. Cervical cancer is the main clinical concern following HPV infection, as it is the fourth most frequent female cancer, with a death rate around 7.5%. In addition, more than 85% of deaths due to cervical cancer are in developing countries. The incidence of cutaneous warts varies with age, with a range from 1 to 12% in the adult general population, but could be over 24% in school age children [5]. Inborn errors of immunity (IEI) are characterized by an impaired immune response, affecting tissue-intrinsic immunity that is either, innate, adaptive, or both. IEI could be associated with higher susceptibility to infections, auto-inflammation, and/or autoimmunity. Unusual clinical expression of HPV infection is frequently observed in patients with IEI. The spectrum of the clinical phenotype is large from epidermodysplasis verruciformis (EV) (a rare disease due to β-HPV) to profuse, persistent and recalcitrant warts (due to α-, γ-, and μ-genera) [6]. Very rare individuals develop tree man syndrome (TMS) due to HPV2 [7]. There are some published reviews and case reports that describe clinical, immunological, and genetic patterns of IEI related to severe HPV cutaneous infections, but there are too many aspects of these issues that are still unknown and are being discovered continuously. Here, we present an up-to-date review of the major clinical, immunological, and genetic patterns of IEI related to severe HPV cutaneous infections, and we propose an algorithm for diagnosis of IEI with severe warts in order to help clinicians who may encounter patients with recurrent and recalcitrant warts due to an underlying inherited immunodeficiency.

2. Clinical Phenotypes

Depending on the HPV genera, there are different characteristics of HPV skin lesions. Macroscopy and histology analyses could help with an appropriate diagnosis.

2.1. Epidermodysplasia Verruciformis

With less than 250 cases reported worldwide, epidermodysplasia verruciformis (EV) is a rare disease that appears at young ages: infancy (7.5% of cases), childhood (61.5% of cases), and adolescence (22% of cases). Lesions are characterized by progressive onset hyperpigmented or achromic flat verrucous lesions, irregular patches of a reddish-brown color, keratotic seborrheic lesions, and pityriasis versicolor-like macules. The lesions are found mainly on sun-exposed areas, such as the face, trunk, neck, forearms, hands, and feet (Figure 1). Although various genotypes of β-HPVs are detected in EV lesions, HPV5 and -8 are found in 80% of cases. Histologic features of an EV lesion are characterized by a flat wart and showing mild to moderate hyperkeratosis, hypergranulosis, and acanthosis of the epidermis. The keratinocytes in the upper layer of the epidermis are enlarged and exhibit a vacuolated nucleus and a pale blue-gray color [8].
Figure 1

Epidermodysplasia verruciformis lesions initially localized on the face, and then generalized to the neck and the trunk in a 12-year-old male patient with STK4 deficiency.

EV can be isolated (typical EV) or syndromic (atypical EV) associated with other clinical manifestations, infectious, or not. [9]. Among 40–50-year-old patients, 30 to 60% of EV patients develop non-melanoma skin cancer, particularly squamous cell carcinoma, occurring in sun-exposed areas. People with black skin have a much lower incidence of skin cancer. Most squamous cell carcinomas remain localized. Metastases are not frequent [8,10].

2.2. Profuse Warts (PWs)

Profuse warts (PWs) are defined as more than 20 lesions in more than one area of the body. If they do not disappear after 6 months of treatment, they are also classified as recalcitrant [11]. PW cauliflower-like papules have a rough, hyperkeratotic surface but they can be flat depending on the HPV involved (Figure 2). PWs are the consequence of an infection with α- or γ-HPV, and less frequently with μ- and ν-HPVs [12]. Histologic analyses of PWs have shown markedly papillomatous epidermis with hypergranulomatosis and overlying tiers of parakeratosis. The upper epidermis may contain large pink inclusions, particularly in cases arising on acral skin. Other lesions have shown smaller basophilic granules. Classically, in the upper epidermis, koilocytes or vacuolated keratinocytes which have a small shrunken nucleus surrounded by a perinuclear halos are observed [13].
Figure 2

Profuse cauliflower and flat warts in a 26-year-old female patient with GATA2 deficiency (DCML syndrome).

2.3. Tree Man Syndrome

In exceptional cases, the warts can also transform into exophytic cutaneous lesions and giant horns, resulting in tree man syndrome [7]. TMS presents with the most extensive warts developing into cutaneous horns, which can be giant and generalized. These lesions start as cutaneous warts, slowly spreading over the hands and feet before transforming into cutaneous horns, characteristic of the TMS phenotype (Figure 3). This condition is extremely rare, with less than 10 cases reported so far. All cases were sporadic with no family history. Due to the paucity of reported cases, it is unclear whether these lesions in TMS have malignant potential [7].
Figure 3

Tree man syndrome giant horns from an HPV2-driven multifocal benign epithelial tumor overexpressing viral oncogenes in the epidermis basal layer in a 30-year-old male patient with CD28 deficiency [7].

3. Immunological Phenotypes and Inborn Errors of Immunity

3.1. No immunological Phenotype in Blood (Skin-Intrinsic Immunity Disorder)

Isolated EV is due to autosomal recessive (AR) mutations in TMC6 and TMC8, which encode EVER1 and EVER2, two endoplasmic reticulum plasma membrane proteins, respectively, and in CIB1, which encodes calcium and integrin binding protein [9,14] (Table 1). Patients with isolated EV did not show any major leukocyte abnormalities, neither quantitative nor qualitative, in terms of proliferation or antibodies production. The HPV proteins, E5 and E8, targeted the EVER1–EVER2–CIB1 complex, strongly suggesting that this complex is acting as a restriction factor to HPVs in keratinocytes. In terms of the physiological mechanism, the dominant hypothesis is that isolated EV is the consequence of IEI affecting the keratinocyte-intrinsic immune response [14].
Table 1

Etiologies and immunological phenotypes of isolated EV.

HPV Phenotype Gene/protein (Mode ofInheritance)Clinical PhenotypesT Cell CountsT FunctionOther Immunological FeaturesReference
Isolated EVTMC6/EVER1 (AR)EVNormalNormalNone[9,14]
TMC8/EVER2 (AR)EVNormal with slightly high proportions for skin-homing subsetsNormalNone
CIB1 (AR)EVNormalNormalNone

AR, autosomal recessive; EV, epidermodysplasia verruciformis; TMC6, transmembrane channel-like protein 6; TMC8, transmembrane channel-like protein 8.

3.2. Immunological Phenotype with Qualitative or/and Quantitative T Cells Defects Only

In contrast to isolated EV, syndromic EV is related to IEI affecting T cells. Some of these IEI are also associated with PW phenotype. For some of them, warts are a major clinical symptom (Table 2) [6]. For instance, in AR DOCK8 deficiency, warts were reported in >40% of patients that were characterized by T and NK cell lymphopenia, and some patients developed α-HPV-induced malignancies [15]. Furthermore, AR mutations in the serine/threonine kinase 4 (STK4) gene are primarily characterized by a reduced amount and survival of circulating naïve T cells. Progressive CD4 T cell lymphopenia with profoundly low naïve CD4 T cell counts is hallmark, while CD8 T cells and NK cells are within normal range. T cell proliferation responses to both antigens and mitogens are markedly impaired. B cell counts are mildly low with hypergammaglobulinemia of IgG and variable increases in IgA and IgE [16].
Table 2

Etiologies, clinical phenotypes, and immunological phenotypes of warts associated with IEI with qualitative or/and quantitative T cell defects.

HPV PhenotypeGene/Protein (Mode ofInheritance)Other ClinicalPhenotypesT Cell CountsT FunctionOther Immunological FeaturesReference
Syndromic EVRHOH (AR)Cutaneous viralinfections,bronchopulmonary disease,Burkitt lymphomaLow naïve CD4+ Tc, high memory CD4+ and CD8+ Tc counts, low proportions of skin-homing Tc subsetsMildly impaired antigen-inducedTc proliferation, no anti-CD3-inducedproliferation-[18,19]
Syndromic EV or profuse wartsSTK4 (AR)Bacterial, candida infections, EBVlymphoproliferation, lymphoma,congenital heartdisease Low TcLow terminal differentiatedeffector memory cells Low naïve TcPoor proliferationImpaired mitogen (PHA, PMA/ionomycin)- and antigen (candida, tetanus toxoid, tuberculin)-induced proliferationIntermittentneutropenia,autoimmunecytopenia,low Bc[16,20,21]
Syndromic EV or profuse wartsDOCK8 (AR)Cutaneousstaphylococcal and viral infections,severe eczema,severe atopyLow Tc CD4+Poor production of antiviral cytokines(TNFα, IFNγ)Hyper IgE,hypereosinophiliaLow IgM[15,22]
Syndromic EV or chronic wartsCORO1A (AR)Severe varicella, molluscum contagiosum andaggressive EBVinfectionLow Tc-Defectivenumber and/or cytolytic activity of NK cells,hypogammaglobulinemia, and defective antibody responses[18,23]
Syndromic EVRASGRP1 (AR)Recurrentpneumonia, herpes virus infections, EBV-associatedlymphomaLow TcTc: poor activation, proliferation,motilityIncreased IgA,Bc: pooractivation,proliferation,motility[6,18,24]
Syndromic EVLCK (AR)Failure to thrive,severe diarrhea,opportunisticinfections Low CD4+Low Tregs,restricted TcrepertoirePoor TCR signalingAutoimmunity,high IgM[18,20,24]
Syndromic EVTPP2 (AR)Evans syndrome (immune thrombocytopenic purpura and autoimmune hemolytic anemia), progressiveLeukopenia, mildviral infections, mild developmental delayNormal or slightly low CD4+ Tc countsSenescent CD8+ Tc (impairedproliferation,enhanced staurosporine-induced apoptosis)Prematureimmunosenescence (Tc and Bc and antinuclear antibodies),normal IgA and IgE levels, IgG and IgM levels high[18,24]
Profuse wartsCARMIL2 (AR)Recurrent bacterial, fungal andmycobacterial infections, molluscum contagiosum, EBV lymphoproliferative syndrome and other malignancy, atopyLow Tregs, high frequency ofnaïve CD4+, but normal CD4+ overallPoor Tc dependent antibody responsePoor Tc functionLow frequency of memory B cellsIg normal or low[17,25]
WartsIKBKG/NFκB essentialmodulator (XL)OpportunisticInfections:P. jirovecii, common, NTM, histoplasma, HSV, CMV, MCV infectionsTc normal or lowTCR activation impairedLow memory and isotype switched Bc,monocytedysfunction,low IgG,some elevated IgG, IgM[18,20,24]
Tree mansyndrome orcommon wartsCD28 (AR)NoneLow Tregs, Low central memory CD4 and CD8 T cellsAbolished CD28 costimulationresponse, impaired T cell proliferation upon antigensstimulation Low NK cells[7]

IEI, inborn errors of immunity; AR, autosomal recessive; XL, X-linked; Tc, T cells, Tregs, T regulators; EV, epidermodysplasia verruciformis; HSV, herpes simplex virus; VZV, varicella zoster virus; DOCK8, dedicator of cytokinesis 8; STK4, serine/threonine protein kinase 4; EBV, Epstein–Barr virus; NTM, nontuberculous mycobacteria; HSV, herpes simplex virus; CMV, cytomegalovirus; MCV, molluscum contagiosum virus; CARMIL2: capping protein regulator and myosin 1 linker 2; RHOH, Ras homolog family member H; IFNγ, interferon γ; TNFα, tumor necrosis factor α; NF-κB, nuclear factor kappa B, IKBKG, inhibitor of nuclear factor kappa B kinase regulatory subunit gamma.

More recently, patients with CARMIL2 and CD28 deficiencies were associated with HPV susceptibility [7,17]. These IEI both affect the CD28 signaling pathway, which is the major costimulatory pathway of TCR. Patients with CARMIL2 deficiency developed disseminated warts among other infectious manifestations, and they also had decreased memory B cells [17], whereas CD28 deficiency was associated with PW only. Interestingly, one of the CD28 patients developed TMS [7].

3.3. Immunological Phenotype with Several Impaired Leukocyte Subsets

This category includes warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome, and classical CID and SCID syndromes (Table 3). The warts are also due to α-HPV and the immunological phenotypes of these diseases are variable but qualitative or/and quantitative T cell defects are common to all of them [24]. For example, in WHIM syndrome, between 60 and 80% of patients develop warts after α-HPV infection, and about 16% of these patients develop HPV-related cancers. This disease is associated with mutations in the CXCR4 gene, encoding a chemokine receptor. The immunological phenotype is characterized by neutropenia, low counts of dendritic cells (DC), memory B cells, and naïve CD4+ and CD8+ T cells [26]. In GATA2 haploinsufficiency, α-HPV infections occur in more than 50% of the cases, and genital cancers are frequent. Low monocyte, DC, B cell, CD4+ T cell, and NK cell counts are the most common immunological features of the patients [18,24].
Table 3

Etiologies, clinical phenotypes, and immunological phenotypes of warts associated with several impaired leukocyte subsets.

Disease Name Gene/Protein (Mode ofInheritance)Other ClinicalPhenotypesT Cell CountsT FunctionOtherImmunological FeaturesReference
WHIM syndromeCXCR4 gof (AD)Warts,genital dysplasiapneumonia,cellulitis, sinusitis, urinary tractinfection,thrombophlebitis, omphalitis,osteomyelitis, soft tissue abscesses, HSV infections, VZV infectionsLowLow LPA/LPMCutaneous anergyLow IgG and IgA,normal antibody responsesneutropenialow Bc:- Low CD27+ Bc- Low IgD+ and IgD-Bc[26]
MonoMacsyndromeDCMLEmbergersyndrome or WILD syndromeGATA2 (AD)Warts,susceptibility tomycobacteria,histoplasmosis, lymphedema,pulmonaryalveolarproteinosis,myelodysplasiaVariable, Low TcVariable, impaired T cell proliferation upon mitogen stimulationMonocytopenia,Low BcLow NK[18,24]
LAD syndromeLAD1/ITGB2 (AR)Warts, delayed cordseparation with omphalitis, no pus formation, lack in inflammation isobserved ininfection area,periodontitisLeukocytosis -Low CD18+neutropenia[18,20,24]
WartsCD154/CD40L, tumor necrosis factor surface family 5 (XL)P. jiroveciipneumonia, chronicwatery diarrhea due to infection withcryptosporidium, liver and biliary tract disease with sclerosingcholangitis due tocryptosporidium parvum, andinfections with hepatitis B and C viruses as well as CMV can result in liver and biliary tract tumors VariableDefect in CD40L productionNeutropenia,autoimmunity with immune TNFSF5thrombocytopenia, hemolytic anemia, andimmunemediatednephritis[18,20]
Syndromic EVDCLRE1C/ARTEMIS(hypomorphic, AR)Recurrentrespiratory and gastrointestinalinfectionsLow CD4+ Tc Impairedproliferativeresponse andreduced counts of naïve T cells,restricted T cellreceptor repertoireLow B cellnumbers andserum IgA levelsincreasedsensitivity toionizingradiation offibroblasts[18,27]
WartsSPINK5 (AR)Congenitalicthyosis, bamboo hair, atopicdiathesis, bacterial infectionsNormal T cell counts, the proportion of naïve CD4+ T cells is reduced and the proportion of CD8+ T central memory elevated-Switched and non-switched Bc are reducedhyper IgE and IgAOther Ig: variably decreasedimpaired NKcytotoxicity[18,20,28]
WartsADA (XL)Chondrosternal dysplasia, deafness,pulmonaryalveolarproteinosis,cognitive defectsLow Tc-Low Bcabsent orreduced ADAactivity (<1% of normal) [18,20,24]

IEI, inborn errors of immunity; AR, autosomal recessive; AD, autosomal dominant; XL, X-linked; Tc, T cell; Bc, B cell; Treg, T regulators; NK, natural killers; LPA, lymphocyte proliferation to antigen; LPM, lymphocyte proliferation to mitogen; gof, gain of function; CXCR4, C-X-C motif chemokine receptor 4; WHIM, warts, hypogammaglobulinemia, infections, and myelokathexis; LAD-1, leukocyte adhesion deficiency type, ADA, adenosine demaminase; MAC, Mycobacterium avium complex; MonoMAC, monocytopenia M. avium complex infection; DCML, dendritic cell, monocyte, B cell, and NK cell lymphopenia; NTM, nontuberculous mycobacteria; SPINK5, serine protease inhibitor Kazal type 5; WILD syndrome: Warts, immunodeficiency, lymphedema, and dysplasia syndrome; DCLRE1C, DNA cross-link repair 1C; ITGB2, integrin beta chain β2.

4. Warts and IEI: Diagnostic Strategy

When an HPV-related clinical manifestation is severe, meaning profuse, chronic or recalcitrant and resistant to treatment, an IEI should be suspected especially if there are other infections, atopy, autoimmunity, or malignancy. Together with familial and patient history and physical examination, a guided differential diagnosis hypothesis should be formulated. Afterwards, focused laboratory testing should be investigated starting with immunoglobulin levels, T cell counts, and T cell subpopulation counts [29]. In Figure 4, we propose an algorithm for laboratory testing orientation for diagnosis of IEI related to HPV susceptibility, with or without impaired leukocyte populations.
Figure 4

Algorithm for laboratory testing orientation to diagnosis IEI with severe warts and lymphopenia. DOCK8, dedicator of cytokinesis 8; EV, epidermodysplasia verruciformis; ADA, adenosine desaminase severe combined immunodeficiency; NEMO, nuclear factor κB essential modulator deficiency; TPP2, tripeptidyl peptidase 2; LCK, lymphocyte-specific protein tyrosine kinase; SPINK5, serine peptidase inhibitor Kazal type 5; STK4, serine/threonine kinase 4; CXCR4, C-X-C motif chemokine receptor 4; CORO1A, coronin 1A, CARMIL2, capping protein regulator and myosin 1 linker 2, RHOH, Ras homolog family member H.

5. Conclusions

HPV skin lesions are a common symptom during infancy to childhood. Although recalcitrant warts, or even EV, are a rare clinical manifestation, physicians, including dermatologists and pediatricians, should consider IEI for a patient with recurrent or disseminated HPV skin lesions. The diagnosis strategy is crucial for a prompt and appropriate treatment of those patients. Furthermore, investigations of patients with EV or PW will increase our understanding of skin-intrinsic host immunity against HPVs.
  24 in total

1.  Natural history of warts. A two-year study.

Authors:  A M MASSING; W L EPSTEIN
Journal:  Arch Dermatol       Date:  1963-03

2.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.

Authors:  Hans-Ulrich Bernard; Robert D Burk; Zigui Chen; Koenraad van Doorslaer; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

Review 3.  Warts (non-genital).

Authors:  Steven King-Fan Loo; William Yuk-Ming Tang
Journal:  BMJ Clin Evid       Date:  2009-09-24

4.  DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.

Authors:  Timo Volk; Ulrich Pannicke; Ismail Reisli; Alla Bulashevska; Julia Ritter; Andrea Björkman; Alejandro A Schäffer; Manfred Fliegauf; Esra H Sayar; Ulrich Salzer; Paul Fisch; Dietmar Pfeifer; Michela Di Virgilio; Hongzhi Cao; Fang Yang; Karin Zimmermann; Sevgi Keles; Zafer Caliskaner; S Ükrü Güner; Detlev Schindler; Lennart Hammarström; Marta Rizzi; Michael Hummel; Qiang Pan-Hammarström; Klaus Schwarz; Bodo Grimbacher
Journal:  Hum Mol Genet       Date:  2015-10-16       Impact factor: 6.150

5.  The phenotype of human STK4 deficiency.

Authors:  Hengameh Abdollahpour; Giridharan Appaswamy; Daniel Kotlarz; Jana Diestelhorst; Rita Beier; Alejandro A Schäffer; E Michael Gertz; Axel Schambach; Hans H Kreipe; Dietmar Pfeifer; Karin R Engelhardt; Nima Rezaei; Bodo Grimbacher; Sabine Lohrmann; Roya Sherkat; Christoph Klein
Journal:  Blood       Date:  2012-01-31       Impact factor: 22.113

6.  Homoeopathic versus placebo therapy of children with warts on the hands: a randomized, double-blind clinical trial.

Authors:  J T Kainz; G Kozel; M Haidvogl; J Smolle
Journal:  Dermatology       Date:  1996       Impact factor: 5.366

Review 7.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

8.  Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.

Authors:  Amandine Crequer; Anja Troeger; Etienne Patin; Cindy S Ma; Capucine Picard; Vincent Pedergnana; Claire Fieschi; Annick Lim; Avinash Abhyankar; Laure Gineau; Ingrid Mueller-Fleckenstein; Monika Schmidt; Alain Taieb; James Krueger; Laurent Abel; Stuart G Tangye; Gérard Orth; David A Williams; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

9.  Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.

Authors:  Anas M Alazami; Maryam Al-Helale; Safa Alhissi; Bandar Al-Saud; Huda Alajlan; Dorota Monies; Zeeshan Shah; Mohamed Abouelhoda; Rand Arnaout; Hasan Al-Dhekri; Nouf S Al-Numair; Hazem Ghebeh; Farrukh Sheikh; Hamoud Al-Mousa
Journal:  Front Immunol       Date:  2018-02-09       Impact factor: 7.561

10.  Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.

Authors:  Aziz Bousfiha; Leila Jeddane; Capucine Picard; Waleed Al-Herz; Fatima Ailal; Talal Chatila; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Jennifer Puck; Troy R Torgerson; Jean-Laurent Casanova; Kathleen E Sullivan; Stuart G Tangye
Journal:  J Clin Immunol       Date:  2020-02-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.